BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33595705)

  • 21. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.
    Harimoto N; Yoshizumi T; Inokuchi S; Itoh S; Adachi E; Ikeda Y; Uchiyama H; Utsunomiya T; Kajiyama K; Kimura K; Kishihara F; Sugimachi K; Tsujita E; Ninomiya M; Fukuzawa K; Maeda T; Shirabe K; Maehara Y
    Ann Surg Oncol; 2018 Oct; 25(11):3316-3323. PubMed ID: 30051372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
    Zheng J; Seier K; Gonen M; Balachandran VP; Kingham TP; D'Angelica MI; Allen PJ; Jarnagin WR; DeMatteo RP
    Ann Surg Oncol; 2017 Nov; 24(12):3706-3714. PubMed ID: 28840521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
    Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
    BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Curatively Resected Gastric Cancer.
    Ju M; Aoyama T; Fukuda M; Ishiguro T; Kano K; Kazama K; Sawazaki S; Tamagawa H; Yukawa N; Rino Y
    Cancer Diagn Progn; 2022; 2(6):627-633. PubMed ID: 36340444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection.
    Tsunematsu M; Haruki K; Fujiwara Y; Furukawa K; Onda S; Matsumoto M; Gocho T; Shiba H; Yanaga K
    Langenbecks Arch Surg; 2021 Feb; 406(1):99-107. PubMed ID: 32936328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
    Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
    J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
    Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion.
    Morkavuk ŞB; Çulcu S; Esen E; Ünal AE
    World J Surg Oncol; 2021 Nov; 19(1):327. PubMed ID: 34781987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.
    Wu T; Zheng Z; Wang J; He M; Wang J; Pan Y; Chen J; Hu D; Zhang Y; Xu L; Chen M; Zhou Z
    J Hepatocell Carcinoma; 2023; 10():2133-2145. PubMed ID: 38058386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
    Suzuki T; Ishibashi Y; Tsujimoto H; Nomura S; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Sugasawa H; Kishi Y; Ueno H
    In Vivo; 2020; 34(6):3705-3711. PubMed ID: 33144487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
    Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
    BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.
    Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y
    Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative serum hyaluronic acid level as a prognostic factor in patients undergoing hepatic resection for hepatocellular carcinoma.
    Mima K; Beppu T; Ishiko T; Chikamoto A; Nakagawa S; Hayashi H; Watanabe M; Sakamaki K; Baba H
    Br J Surg; 2014 Feb; 101(3):269-76. PubMed ID: 24446084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection.
    Imai D; Maeda T; Shimokawa M; Wang H; Yoshiya S; Takeishi K; Itoh S; Harada N; Ikegami T; Yoshizumi T; Mori M
    Hepatol Res; 2020 Jan; 50(1):101-109. PubMed ID: 31692173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor volume measured using MR volumetry as a predictor of prognosis after surgical resection of single hepatocellular carcinoma.
    Jeon SK; Lee DH; Park J; Suh KS; Yi NJ; Hong SK; Han JK
    Eur J Radiol; 2021 Nov; 144():109962. PubMed ID: 34562746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
    Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
    Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of Pre-surgical Combined Platelet Count and Neutrophil-Lymphocyte Ratio for Patients With Hepatocellular Carcinoma.
    Uchinaka EI; Amisaki M; Yagyu T; Morimoto M; Watanabe J; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    In Vivo; 2019; 33(6):2241-2248. PubMed ID: 31662563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.